TOPLINE: The introduction of highly effective modulator (elexacaftor/tezacaftor/ivacaftor) therapy improved the disease trajectory of cystic fibrosis (CF). However, its benefits were less pronounced for lung transplant candidates of Black or Hispanic ethnicity than for those of White ethnicity. METHODOLOGY: Researchers evaluated the differences in lung transplantation outcomes by race/ethnicity in patients with CF using data ...
GET PAID FOR SHOPPING AT ALL YOUR FAVORITE STORES!
Sound too good to be true? Here’s the deal: Stores pay us a commission for sending you their way.
We share that with you as Cash Back. Everyone wins! SIGN UP FOR FREE!
.png)
COOL ROOM ENTERTAINMENT 10530 Campus Way South #1174 Largo, MD 20774
(916) 619-1308
teosmoot@gmail.com
Copyright © 2024 Cool Room Entertainment. All Rights Reserved
